Patents Assigned to Precision Pharmaceuticals, Inc.
  • Compositions and methods for inhibiting arginase activity
    Patent number: 12054501
    Abstract: The disclosure relates to a novel class of compounds that exhibit activity inhibitory activity toward arginase, and pharmaceutical compositions comprising the compounds of the disclosure. Also provided herein are methods of treating cancer with the arginase inhibitors of the disclosure.
    Type: Grant
    Filed: January 20, 2021
    Date of Patent: August 6, 2024
    Assignee: Precision Pharmaceuticals, Inc.
    Inventors: Eric B. Sjogren, Jim Li, Lijing Chen, Roland J. Billedeau, Timothy F. Stanton, Michael Van Zandt, Darren Whitehouse, Gunnar E. Jagdmann, Jr., Lene Raunkjaer Petersen